Our adipogenesis differentiation medium has been specifically developed and optimized for in vitro mesenchymal stem cell adipogenesis study. Generally, with this medium, we obtain >35% mature adipocytes from human bone marrow, >50% from rat bone marrow, and >60% from human mesenchymal stem cell isolated from adipose tissue. Efficiency of adipogenic differentiation depends on the quanlity of the mesenchymal stem cells. Mesenchymal stem cell Adipogenic Differentiation Medium (MADM) is a sterile, liquid medium which contains essential and non-essential amino acids, vitamins, organic and inorganic compounds, hormones, growth factors, trace minerals. The medium is HEPES and bicarbonate buffered and has a pH of 7.4 when equilibrated in an incubator with an atmosphere of 5% CO2/95% air. Components MADM consists of 500 ml of basal medium, 25 ml of fetal bovine serum (FBS, Cat. No. 0025), 5 ml of mesenchymal stem cell adipogenic differentiation supplement (MADS, Cat. No. 7542-5), 5 ml of penicillin/streptomycin solution (P/S, Cat. No. 0503). Note: MADS may be slightly hazy; Haziness does not affect cell culture and differentiation efficiency.
|
貨號(hào)
|
7541
|
|
產(chǎn)地
|
美國
|
|
縮寫
|
MADM
|
|
規(guī)格
|
500ml
|
|
用途
|
科研
|
|
儲(chǔ)存
|
4度，-20度
|
|
運(yùn)輸
|
膠冰
|
|
關(guān)鍵字
|
間充質(zhì)干細(xì)胞-脂肪細(xì)胞分化培養(yǎng)基 MADM 間充質(zhì)干細(xì)胞-脂肪細(xì)胞分化培養(yǎng)基 MADM 間充質(zhì)干細(xì)胞-脂肪細(xì)胞分化培養(yǎng)基 MADM 間充質(zhì)干細(xì)胞-脂肪細(xì)胞分化培養(yǎng)基 MADM 間充質(zhì)干細(xì)胞-脂肪細(xì)胞分化培養(yǎng)基 MADM 間充質(zhì)干細(xì)胞-脂肪細(xì)胞分化培養(yǎng)基 MADM
|
公司簡介
|
合肥星肽生物科技有限公司作為專業(yè)的ScienCell中國代理商，專業(yè)經(jīng)營實(shí)驗(yàn)室科研用原代細(xì)胞、原代細(xì)胞專用培養(yǎng)基、原代細(xì)胞無血清培養(yǎng)基、干細(xì)胞、干細(xì)胞培養(yǎng)基、干細(xì)胞無血清培養(yǎng)基的研究和開發(fā)。合肥星肽生物科技有限公司始終致力于為客戶提供可靠的研究材料以及方便快捷的服務(wù)，對(duì)購買項(xiàng)目的前期資料提供,中期合同保證,后期貨物跟蹤到 *終售后的確保項(xiàng)目準(zhǔn)確到位，都有相關(guān)專業(yè)人士進(jìn)行維護(hù),確保您在合肥合肥星肽生物科技有限公司公司獲得*上等服務(wù)！ 上海 安徽 合肥 ScienCell細(xì)胞庫
|
|
聯(lián)系方式
|
何經(jīng)理，合肥星肽生物科技有限公司，Tel：0551-63802898 400-8702-898，
E-mail：info@qingbio.com http://www.28888123.cn QQ:514713116
|
1.) Moniri MR, Sun XY, Rayat J, Dai D, Ao Z, He Z, Verchere CB, Dai LJ, Warnock GL. (2012) "TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells." Cancer Gene Ther. 19: 652-8.
There are no product questions yet.
